Eli Lilly's Zepbound is the first and only approved dual GLP-1/GIP agonist, and Lilly is also working on its own triple ...

And I was like, ‘That’s absolutely not going to happen.’” Back then, Koziol was deep in the grips of an eating disorder that ...